Tag: Matt Edwards
Diabetes resupply: Preserve dual access
August 12, 2025Matt Edwards
Q. Why does the path to a CGM matter, and should patient choice lead the way?
A. The way a patient receives their CGM—through a pharmacy or a DME provider—can have a meaningful impact on adherence, outcomes and health care costs. That’s why it’s essential to protect patient and physician choice in determining the best delivery channel.
Studies consistently show that the DME pathway supports stronger adherence and long-term success. One study in JMIR Diabetes...
Diabetes resupply: Train early, often
July 8, 2025Matt Edwards
Q. What challenges should I expect when managing CGM resupply—and how do I overcome them?
A. There are several operational, regulatory and clinical challenges to overcome, but understanding and proactively addressing potential challenges at the start of a CGM program is key to its success and sustainability.
Insurance complexity is a common challenge. CGM products may fall under both pharmacy and medical benefits, which can confuse patients and providers. Pharmacy and...
Diabetes Resupply: Establish infrastructure
June 17, 2025Matt Edwards
Q. How do HME businesses get started with a CGM resupply program?
A. Most HME providers already possess the foundational capabilities needed for a CGM resupply program—such as patient outreach, billing expertise and established provider relationships. Success lies in integrating these assets into a scalable, compliant and patient-centered model.
The first step is to review payer contracts. Continuous glucose monitors may be covered under the medical benefit (via...
Diabetes Resupply: Seize the CGM opportunity
May 6, 2025Matt Edwards
Q. Why should HME providers consider launching a continuous glucose monitor resupply program now?
A. Diabetes impacts more than 37 million Americans, many of whom rely on daily glucose monitoring to manage their condition and prevent serious complications. In recent years, the standard of care has evolved with the widespread adoption of CGMs—small, wearable devices that provide real-time glucose readings through a sensor placed under the skin. As these devices become more mainstream,...